Powered by: Motilal Oswal
13/10/2021 2:24:43 PM | Source: HDFC Securities Ltd
Emargin Positional Pick - Buy Sequent Scientific Ltd For Target Rs. 244 - HDFC Securities
News By Tags | #2034 #2239 #3050 #642
Emargin Positional Pick - Buy Sequent Scientific Ltd For Target Rs. 244 - HDFC Securities

Emargin Positional Pick - Buy Sequent Scientific Ltd For Target Rs. 244  - HDFC Securities

After showing sideways range movement in the last few weeks, the stock price has shifted into an upside bounce in this week.

Presently, the stock price is making an attempt to stage upside breakout of the crucial overhead resistance around Rs 225 levels. Hence, a sustainable move above this area could open a sharp upside breakout.

The down trend of the last few months seems to have completed with the bottom formation of Rs 198 in the week before last.

Weekly 14 period RSI has turned up from 40 levels, which signal further strengthening of upside momentum in the stock price ahead.

The overall chart pattern of SEQUENT indicates long trading opportunity. One may look to create positional long as per the levels mentioned above.

Buy Sequent Scientific Ltd Up to 3 Months @ Add on dips 208.50 CMP 221.15 TGT 244 SL 202.50

 


To Read Complete Report & Disclaimer Click Here

 

Please refer disclaimer at https://www.hdfcsec.com/article/disclaimer-1795

SEBI Registration number is INZ000171337

 

Above views are of the author and not of the website kindly read disclaimer

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here